Work

Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer

Year: 2025

Type: article

Source: Prostate Cancer and Prostatic Diseases

DOI: 10.1038/s41391-025-01041-z

Authors: Xiaolei Shi, Jarey H. Wang, Brian F. Chapin, Ana Aparicio, Sumit K. Subudhi, Phuoc T. Tran, Ryan J. Park, Matthew P. Deek, Hong Zhang, Kevin C. Bylund, Micheal Cummings, Andrew J. Armstrong, Chad Tang, Philip Sutera

Institutions: University of Maryland Medical Center, Johns Hopkins University, Johns Hopkins Medicine, The University of Texas MD Anderson Cancer Center, University of Maryland, Baltimore, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, University of Rochester Medicine, University of Rochester, Duke University, Duke Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute

Awards: G135985217, Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer, W81XWH-21-1-0296/NOVEL BIOMARKERS TO DIRECT STEREOTACTIC ABLATIVE RADIOTHERAPY IN CASTRATION-SENSITIVE OLIGOMETASTATIC PROSTATE CANCER., G9000354708, Training Grant in Cancer Biology

OpenAlex ID: W4415076278

FWCI: 1.177

Cites: 90

Cited by: 2

Related to: